In a high-fat diet-induced obesity and nonalcoholic fatty liver mouse model, injection of recombinant ISM1 can effectively reverse hepatic steatosis, which may provide a new direction for clinical treatment of metabolic diseases (Jiang et al. 2021). Here, ISM1 is linked to metabolic disease.